The purpose of this study is to test an experimental drug called RMC-6236. RMC-6236 is an experimental drug, which means that it is not approved by the United States (US) Food and Drug Administration (FDA) or any other health authorities. RMC-6236 is currently being investigated in other ongoing studies in non-small cell lung cancer (NSCLC). If you consent and meet the study requirements, you will be randomly assigned to receive either RMC-6236 or docetaxel.
We want you to help us understand an important part of people's lives in the United States: how they think about who they are. We need your help to make our questions clearer. Your feedback will help us create better surveys for everyone. If you join the study, you will look at some draft questions and tell us what you think.
Our research team has created a Bluetooth enabled resistance exercise band (BandPass) and a corresponding workout 'app' to help older adults' strength train at home. The purpose of this project is to test the likelihood that BandPass can be used by older adults, to test whether older adults will keep using the device to exercise during the study, and to test if older adults have improved strength at the end of the study.
We are doing this study to test a behavioral weight loss program designed specifically for adolescent and young adult cancer survivors. Study participants will use technology, including a digital smart scale, Fitbit activity tracker, and study web app to help them lose weight.
We are doing a study to learn how the brain and muscles work together after a person has a stroke. We want to find out if a special type of brain stimulation, which doesn't need surgery, can help improve this connection.
The purpose of this study is to evaluate the efficacy and safety of zilovertamab vedotin plus R-CHP versus polatuzumab vedotin plus R-CHP for the treatment of the GCB subtype of DLBCL.
This study wants to see if adults who don't exercise much can walk at a steady speed (100 steps per minute) for 10 minutes on a treadmill, a sidewalk, and a nature trail. We also want to know how they feel and what mood they are in while walking. This study will help us find fun ways to encourage more people to be active.
In this study, we want to find out if Caring Connections can help prevent suicide for underserved youth and their caregivers. We hope this program can make a positive impact on their lives.
If you have Leukemia and are looking for an alternative treatment, you may be eligible to participate in a research study testing a new drug called AUTX-007.
We are interested in talking to people with chronic non-cancer pain about their experiences of receiving treatment in the UNC Health System, especially times that they felt particularly empowered or disempowered. Participation includes one focus group lasting 60 to 90 minutes.